Literature DB >> 15186936

Taenia solium metacestode glycoproteins as diagnostic antigens for solitary cysticercus granuloma in Indian patients.

V Prabhakaran1, V Rajshekhar, K D Murrell, A Oommen.   

Abstract

Taenia solium metacestode glycoproteins specific for lentil lectin were evaluated as diagnostic antigens for solitary cysticercus granulomas in Indian patients, using both an ELISA and immunoblotting. In 250 patients suspected to have neurocysticercosis and subjected to a computerized tomography scan or magnetic resonance imaging, the proteins were diagnostic by the ELISA in 86 patients (80%) and by immunoblots in 67 (62%) of 107 patients with solitary cysticerus granuloma. Among 100 non-cysticercosis patients, the ELISA and immunoblot were negative in 94% and 97% respectively. No cross-reactions were observed with sera from patients with central nervous system tuberculosis. Proteins of </=18 kDa were the most diagnostic for solitary cysticercus granuloma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15186936     DOI: 10.1016/j.trstmh.2003.12.006

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  15 in total

1.  Evaluation of lower molecular mass (20-24 kDa) Taenia solium cysticercus antigen fraction by ELISA and dot blot for the serodiagnosis of neurocysticercosis in children.

Authors:  Jharna Mandal; Pratibha D Singhi; Niranjan Khandelwal; Nancy Malla
Journal:  Parasitol Res       Date:  2008-03-06       Impact factor: 2.289

2.  The role of conventional MR imaging sequences in the evaluation of neurocysticercosis: impact on characterization of the scolex and lesion burden.

Authors:  L T Lucato; M S Guedes; J R Sato; L A Bacheschi; L R Machado; C C Leite
Journal:  AJNR Am J Neuroradiol       Date:  2007-09       Impact factor: 3.825

Review 3.  Hydrocephalus in neurocysticercosis.

Authors:  Hamilton Matushita; Fernando Campos Gomes Pinto; Daniel Dante Cardeal; Manoel Jacobsen Teixeira
Journal:  Childs Nerv Syst       Date:  2011-09-17       Impact factor: 1.475

4.  Neurocysticercosis, IgG immunoglobulins, and nitric oxide.

Authors:  Vasudevan Prabhakaran; Tharmalingam Jayaraman; Vedantam Rajshekhar; Anna Oommen
Journal:  Parasitol Res       Date:  2010-02-27       Impact factor: 2.289

5.  Human neurocysticercosis: comparison of different diagnostic tests using cerebrospinal fluid.

Authors:  Lorraine Michelet; Agnès Fleury; Edda Sciutto; Eric Kendjo; Gladis Fragoso; Luc Paris; Bernard Bouteille
Journal:  J Clin Microbiol       Date:  2010-11-10       Impact factor: 5.948

Review 6.  Human cysticercosis and Indian scenario: a review.

Authors:  Kashi Nath Prasad; Amit Prasad; Avantika Verma; Aloukick Kumar Singh
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

Review 7.  Update on eosinophilic meningoencephalitis and its clinical relevance.

Authors:  Carlos Graeff-Teixeira; Ana Cristina Arámburu da Silva; Kentaro Yoshimura
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

Review 8.  Immunodiagnosis of neurocysticercosis: ways to focus on the challenge.

Authors:  M Esquivel-Velázquez; P Ostoa-Saloma; J Morales-Montor; R Hernández-Bello; C Larralde
Journal:  J Biomed Biotechnol       Date:  2011-10-29

Review 9.  Neurocysticercosis: neglected but not forgotten.

Authors:  Christina M Coyle; Siddhartha Mahanty; Joseph R Zunt; Mitchell T Wallin; Paul T Cantey; A Clinton White; Seth E O'Neal; Jose A Serpa; Paul M Southern; Patricia Wilkins; Anne E McCarthy; Elizabeth S Higgs; Theodore E Nash
Journal:  PLoS Negl Trop Dis       Date:  2012-05-29

10.  Imaging correlates of serum enzyme-linked immunoelectrotransfer blot (EITB) positivity in patients with parenchymal neurocysticercosis: results from 521 patients.

Authors:  Prabhakaran Vasudevan; Ranjith K Moorthy; Grace Rebekah; Ellen Jackson; Betcy Evangeline Pamela; Subashini Thamizhmaran; Josephin Manoj; Anupriya Thanigachalam; Douglas Drevets; Hélène Carabin; Vedantam Rajshekhar
Journal:  Trans R Soc Trop Med Hyg       Date:  2022-02-01       Impact factor: 2.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.